A detailed history of Northwest Investment Counselors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Northwest Investment Counselors, LLC holds 4,805 shares of NVO stock, worth $572,131. This represents 0.18% of its overall portfolio holdings.

Number of Shares
4,805
Previous 4,598 4.5%
Holding current value
$572,131
Previous $590,000 16.1%
% of portfolio
0.18%
Previous 0.15%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

BUY
$122.71 - $146.91 $25,400 - $30,410
207 Added 4.5%
4,805 $685,000
Q3 2023

Oct 12, 2023

BUY
$90.94 - $199.54 $209,071 - $458,742
2,299 Added 100.0%
4,598 $418,000
Q2 2023

Jul 11, 2023

BUY
$155.98 - $172.65 $7,798 - $8,632
50 Added 2.22%
2,299 $372,000
Q3 2022

Oct 28, 2022

SELL
$95.28 - $116.93 $3,525 - $4,326
-37 Reduced 1.62%
2,249 $224,000
Q1 2022

Apr 18, 2022

BUY
$93.1 - $112.54 $3,444 - $4,163
37 Added 1.65%
2,286 $254,000
Q3 2021

Oct 19, 2021

BUY
$84.42 - $106.62 $189,860 - $239,788
2,249 New
2,249 $216,000
Q2 2021

Jul 22, 2021

SELL
$67.66 - $84.76 $152,167 - $190,625
-2,249 Closed
0 $0
Q1 2021

Apr 20, 2021

BUY
$67.06 - $75.82 $150,817 - $170,519
2,249 New
2,249 $152,000
Q4 2020

Jan 26, 2021

SELL
$63.89 - $73.8 $134,680 - $155,570
-2,108 Closed
0 $0
Q3 2020

Oct 21, 2020

BUY
$63.69 - $70.22 $134,258 - $148,023
2,108 New
2,108 $146,000
Q4 2019

Jan 27, 2020

SELL
$49.86 - $58.26 $105,104 - $122,812
-2,108 Closed
0 $0
Q3 2019

Oct 30, 2019

BUY
$47.54 - $53.43 $100,214 - $112,630
2,108 New
2,108 $109,000
Q4 2017

Feb 01, 2018

SELL
$47.53 - $53.73 $99,004 - $111,919
-2,083 Closed
0 $0
Q3 2017

Oct 30, 2017

BUY
$41.15 - $49.22 $85,715 - $102,525
2,083
2,083 $100,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $269B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Northwest Investment Counselors, LLC Portfolio

Follow Northwest Investment Counselors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Investment Counselors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northwest Investment Counselors, LLC with notifications on news.